Abstract
Diabetes mellitus is a common health problem worldwide counting about 1.2 million cases in Iraq in 2015. Taking in account of the patient’s beliefs about the prescribed medication had been reported to be one of the most important factors that affects adherence where holding positive beliefs about medications is a prerequisite for intentional adherence. The aim of the current study was to investigate and assess beliefs about medicines among type 2 diabetic patients and to determine possible association between this belief and glycemic control as well as some patient-specific factors. This study is a cross-sectional study carried out on 380 (mean age 56.58± 10.06 years) already diagnosed T2DM patients who attended the National Diabetes Center, Al-Mustansiriya University – Baghdad/ Iraq during December-2016 to March-2017. Belief about medicine was assessed by using an arabic version of the questionnaire. The patients had a stronger agreement with the mean necessity scale (19.29) than the mean concern scale (14.27). The majority of the patients (76.3%) had strong beliefs in the necessity of anti-diabetic treatment for maintaining good control of diabetes (scores of specific-necessity was greater than score of specific-concern). However, (18.4%) of the patients reported strong concerns about the anti-diabetic treatment (scores of specific-concern greater than score of specific-necessity). The small number of the patients (5.3%), have equal scores for specific-necessity and specific-concern scores. The patient's belief about medicine was found to be poor predictor of good glycemic control.
Highlights
Diabetes mellitus (DM) is defined by the American Diabetes Association (ADA) as a metabolic disorders characterized hyperglycemia due to defects in insulin secretion and/ or insulin were living with diabetes in 2014, compared to 108 million in 1980 [2]
Taking account of the patient’s beliefs about the prescribed medication had been reported to be one of the most important factors that affects adherence where holding positive beliefs about medications is a prerequisite for intentional adherence [4, 11, 12]
The personal characteristics of the participants involved in the current study and comparison with glycemic control are shown in table-1
Summary
Diabetes mellitus (DM) is defined by the American Diabetes Association (ADA) as a metabolic disorders characterized hyperglycemia due to defects in insulin secretion and/ or insulin were living with diabetes in 2014, compared to 108 million in 1980 [2]. Clinical characteristics of individuals (including duration of disease, experience of taking medicines) have been shown to be related to beliefs in medicines [8, 10]. The BMQ questionnaire is a selfadministered questionnaire, which focuses directly on the beliefs and concerns of the patient about the use and efficacy of medicines. It can be used for a wide range of diseases where prescribed medication is required [13]. The aim of the current study was to investigate and assess beliefs about medicines, among type 2 diabetic patients and to determine possible association between this belief and glycemic control as well as some patientspecific factors
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
